CHESTStoreProductsRespiratory Syncytial Virus RSV Measuring the Impact and Vaccine Prevention

Respiratory Syncytial Virus (RSV): Measuring the Impact and Vaccine Prevention

  • e-Learning

This interactive resource is available as part of the CHEST e-Learning Library subscription.
Access this and other e-learning activities by clicking the button below.

View e-Learning Library


There is important work to be done in raising awareness and providing education around the RSV disease state and the risks involved, especially to protect compromised groups. This interactive infographic delves into the severity of RSV, with a particular focus on patients who present with comorbidities such as COPD, asthma, and other underlying lung-related conditions.

Learning Objectives

  • Identify RSV pathophysiology
  • Describe risk factors, impact, and potential complications of RSV in older adults
  • Relate the importance of protecting older adults at risk for serious complications as a result of respiratory comorbidities
  • Prepare to implement new and emerging vaccines and illustrate their role in the prevention of RSV in adults

Publication expiration date: January 27, 2027

Item Number: 92959.2

Megan Conroy, MD, MAEd, FCCP
Assistant Professor of Medicine, Clinical
Assistant Program Director, Pulmonary &
Critical Care Fellowship
The Ohio State University
Columbus, Ohio

Ryan Maves, MD, FCCP
Professor of Medicine and Anesthesiology
Sections of Infectious Diseases and
Critical Care Medicine
Wake Forest University School of Medicine
Winston-Salem, North Carolina

Kelly M. Pennington, MD
Assistant Professor of Medicine
Assistant Program Director, ALD and
Lung Transplant Fellowship
Mayo Clinic
Rochester, Minnesota

Members receive discounts on many products and events.

Already have an account?